Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura.

Page, Evaren E; Kremer Hovinga, Johanna Anna; Terrell, Deirdra R; Vesely, Sara K; George, James N (2016). Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura. Blood, 128(17), pp. 2175-2178. American Society of Hematology 10.1182/blood-2016-06-724161

[img] Text
JKH_Clinical importance of ADAMTS13.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (599kB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Unit Childrens Hospital > Forschungsgruppe Hämatologie (Erwachsene)

UniBE Contributor:

Kremer Hovinga, Johanna Anna

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0006-4971

Publisher:

American Society of Hematology

Language:

English

Submitter:

Katrin Kölliker-Schütz

Date Deposited:

23 Mar 2017 11:36

Last Modified:

11 Oct 2017 14:30

Publisher DOI:

10.1182/blood-2016-06-724161

PubMed ID:

27625362

BORIS DOI:

10.7892/boris.93091

URI:

https://boris.unibe.ch/id/eprint/93091

Actions (login required)

Edit item Edit item
Provide Feedback